Peter Cicala - Apr 26, 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Director
Signature
/s/ Peter Cicala
Stock symbol
ERNA
Transactions as of
Apr 26, 2024
Transactions value $
$0
Form type
4
Date filed
4/29/2024, 04:31 PM
Previous filing
Feb 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (Right to buy) Award $0 +88.9K $0.00 88.9K Apr 26, 2024 Common Stock 88.9K $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 100% of the number of shares subject to the stock option on the one-year anniversary of the grant date.